Hiccup Clinical Trial
Official title:
A Feasibility Double-Blinded, Randomized Study of Educational Materials for Hiccups
NCT number | NCT05313685 |
Other study ID # | 21-012057 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | December 6, 2021 |
Est. completion date | March 25, 2022 |
Verified date | June 2022 |
Source | Mayo Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a research study about hiccup educational materials. The purpose of this study is to learn whether this type of research can be done.
Status | Completed |
Enrollment | 50 |
Est. completion date | March 25, 2022 |
Est. primary completion date | February 23, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age = 18 years of age. - Hiccups in the 4 weeks prior to phone contact (patient must confirm). - Able to speak and read English. - Has an e-mail address. Exclusion Criteria: - Individuals < 18 years of age. |
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic Rochester | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of enrollment | This is a feasibility study that seeks to enroll 20 patients with hiccups in 5 months from the start of trial recruitment. | 5 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05749159 -
New Physitherapy or Alternative Therapy for Hiccup
|
N/A | |
Withdrawn |
NCT01277731 -
Methylprednisolone Replacement for Dexamethasone-induced Hiccup
|
N/A | |
Not yet recruiting |
NCT03778281 -
Treatment of Chemotherapy-related Hiccups With Baclofen
|
Phase 4 |